Scott Centea - Net Worth and Insider Trading

Scott Centea Net Worth

The estimated net worth of Scott Centea is at least $268,678 dollars as of 2024-04-28. Scott Centea is the Sr. VP/GM, Global VIT of AngioDynamics Inc and owns about 46,244 shares of AngioDynamics Inc (ANGO) stock worth over $268,678. Details can be seen in Scott Centea's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott Centea has not made any transactions after 2021-10-15 and currently still holds the listed stock(s).

Transaction Summary of Scott Centea

To

Scott Centea Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott Centea owns 1 companies in total, including AngioDynamics Inc (ANGO) .

Click here to see the complete history of Scott Centea’s form 4 insider trades.

Insider Ownership Summary of Scott Centea

Ticker Comapny Transaction Date Type of Owner
ANGO AngioDynamics Inc 2023-07-14 SVP/GM & VIT

Scott Centea Latest Holdings Summary

Scott Centea currently owns a total of 1 stock. Scott Centea owns 46,244 shares of AngioDynamics Inc (ANGO) as of October 15, 2021, with a value of $268,678.

Latest Holdings of Scott Centea

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANGO AngioDynamics Inc 2021-10-15 46,244 5.81 268,678

Holding Weightings of Scott Centea


Scott Centea Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott Centea has made a total of 1 transactions in AngioDynamics Inc (ANGO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in AngioDynamics Inc is the sale of 12,000 shares on October 15, 2021, which brought Scott Centea around $335,040.

Insider Trading History of Scott Centea

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott Centea Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Scott Centea Ownership Network

Ownership Network List of Scott Centea

No Data

Ownership Network Relation of Scott Centea


Scott Centea Owned Company Details

What does AngioDynamics Inc do?

Who are the key executives at AngioDynamics Inc?

Scott Centea is the SVP/GM & VIT of AngioDynamics Inc. Other key executives at AngioDynamics Inc include director & President and CEO James C Clemmer , SVP Global Operations and R&D Dave Helsel , and SVP International Laura Piccinini .

AngioDynamics Inc (ANGO) Insider Trades Summary

Over the past 18 months, Scott Centea made no insider transaction in AngioDynamics Inc (ANGO). Other recent insider transactions involving AngioDynamics Inc (ANGO) include a net purchase of 10,000 shares made by James C Clemmer , and a net sale of 4,633 shares made by Dave Helsel .

In summary, during the past 3 months, insiders sold 0 shares of AngioDynamics Inc (ANGO) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 4,633 shares of AngioDynamics Inc (ANGO) were sold and 10,000 shares were bought by its insiders, resulting in a net purchase of 5,367 shares.

AngioDynamics Inc (ANGO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AngioDynamics Inc Insider Transactions

No Available Data

Scott Centea Mailing Address

Above is the net worth, insider trading, and ownership report for Scott Centea. You might contact Scott Centea via mailing address: C/o Angiodynamics, Inc., 14 Plaza Drive, Latham Ny 12110.

Discussions on Scott Centea

No discussions yet.